Clinical trial
Wild Type p53 Adenovirus for Oral Premalignancies
NCT00410865 · M.D. Anderson Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00410865 |
|---|---|
| Title | Wild Type p53 Adenovirus for Oral Premalignancies |
| Official title | Clinical Protocol for Wild Type p53 Gene Induction in Premalignancies of Squamous Epithelium of the Oral Cavity and Oral Pharynx Via an Adenoviral Vector [NCI Supplied Agent Ad-p53, (INGN 201) (Advexin®) NSC 683550, IND# 7135] |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH Department of Health and Human Services U.S. Fed |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Mouth Cancer |
| Intervention type | Genetic |
| Interventions | INGN 201 |
| Enrollment | 4 |
| Start date | Jun 1, 2003 |
| Primary completion | Mar 1, 2008 |
| Completion | Nov 1, 2010 |
| First posted | Dec 13, 2006 |
| Last update posted | Dec 7, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: